Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,615.60
(
0.23%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
102.61
(
0.49%
)
Bitcoin
77,170.91
(
-0.26%
)
News Focus
News Focus
Post# of 257454
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: oc631 post# 251814

Thursday, 05/23/2024 4:46:39 PM

Thursday, May 23, 2024 4:46:39 PM

Post# of 257454

What if Nuvaxovid isn't approved in the U.S. by the 2025/2026 season? If you have followed NVAX in the past don't say this can't happen.



Filip Dubovsky head of R&D at NVAX to retire. The only person with redeemable value at this organization IMO.


https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=318344316&type=HTML&symbol=NVAX&cdn=c539b5e2b1680d82aeda2a9a50c04b46&companyName=Novavax+Inc.&formType=8-K&dateFiled=2024-05-23
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today